Clinical Trials Logo

Clinical Trial Summary

The Thermedical Ablation System and Durablate catheter is indicated for use in patients with recurrent, sustained, monomorphic ventricular tachycardia (SMVT) refractory to drug therapy and conventional (approved) catheter ablation. Subjects with recurrent, SMVT refractory to drug therapy and conventional catheter ablation who are not eligible for, or will not likely benefit from repeat endocardial ablation using an approved catheter.


Clinical Trial Description

This is a staged, non-randomized, open-label, single group, interventional study to be conducted at up to 25 investigational sites to evaluate the safety and efficacy of the Thermedical Ablation System with the Durablate Ablation Catheter (investigational device) in subjects with recurrent, sustained, monomorphic ventricular tachycardia (VT) refractory to drug therapy and conventional catheter ablation. Subjects will be consented (enrolled) and screened prior to the study ablation procedure. 154 subjects will have a study ablation procedure with the investigational device. Follow-up will occur at 7 days, 30 days, 3 months and 6 months. The single arm design of the proposed study reflects the nature of the study population. The Thermedical Ablation System was designated as a Breakthrough technology in part because no currently approved device specifically treats this refractory patient population. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05337241
Study type Interventional
Source Thermedical, Inc.
Contact Michael Curley, PhD
Phone 617-899-9843
Email mcurley@thermedical.com
Status Not yet recruiting
Phase N/A
Start date November 1, 2022
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04066517 - STereotactic RadioAblation by Multimodal Imaging for VT (STRA-MI-VT) N/A
Not yet recruiting NCT02646501 - Prospective Randomized Clinical Trial for Effect of Stellate Ganglion Block in Medically Refractory Ventricular Tachycardia N/A
Recruiting NCT06294782 - PrOsPective Cohort Study for STereotactic Arhythmia Radioablation (STAR) of Refractory Ventricular Tachycardia N/A
Completed NCT03349892 - Stereotactic Ablative Radiotherapy for Refractory Ventricular Tachycardia N/A